title: Excessively increased CSF tau in progressive multifocal leukoencephalopathy.
authors.affiliation: Department of Neurology, University of Lübeck, Lübeck, Germany. norbert.brueggemann@neuro.uni-luebeck.de
authors.forename: Norbert
authors.initials: N
authors.lastname: Brüggemann
authors.forename: Stefan
authors.initials: S
authors.lastname: Gottschalk
authors.forename: Detlev
authors.initials: D
authors.lastname: Körtke
authors.forename: Jan H
authors.initials: JH
authors.lastname: Marxsen
authors.forename: Andreas
authors.initials: A
authors.lastname: Moser
mesh_terms: D000368:Aged; D016229:Amyloid beta-Peptides / Q000134:cerebrospinal fluid; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001284:Atrophy; D001921:Brain / Q000473:pathology; D006801:Humans; D007968:Leukoencephalopathy, Progressive Multifocal / Q000134:cerebrospinal fluid*; D016393:Lymphoma, B-Cell / Q000150:complications / Q000188:drug therapy; D008279:Magnetic Resonance Imaging; D008297:Male; D010446:Peptide Fragments / Q000134:cerebrospinal fluid; D000069283:Rituximab; D016875:tau Proteins / Q000134:cerebrospinal fluid*
chemical_list: D016229:Amyloid beta-Peptides; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D010446:Peptide Fragments; C075222:amyloid beta-protein (1-42); D016875:tau Proteins; D000069283:Rituximab